In line with our study, a meta-analysis found that IRS2 rs1805097G>A polymorphism, leading to an aspartate replaced by glycine in the codon 1057 of its gene, changed the structure and function of the IRS2 protein and lowered the risk of overall CRC (78). This evidence concerns the gene IRS2 and colorectal carcinoma.